Vitasora Health (ASX:VHL) PS Ratio: 4.33 (As of Jul. 07, 2026) — 64% Below Median


What is Vitasora Health PS Ratio?

Vitasora Health ASX:VHL +18.18% PS Ratio is 4.33 as of Jul. 07, 2026, which is 64% below its 10-year median of 12.00. The stock has 6 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Vitasora Health ranks worse than 74.89% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Vitasora Health's share price is A$0.013. Vitasora Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Hence, Vitasora Health's PS Ratio for today is 4.33.

The historical rank and industry rank for Vitasora Health's PS Ratio or its related term are showing as below:

ASX:VHL' s PS Ratio Range Over the Past 10 Years
Min: 3.67   Med: 12   Max: 16
Current: 4.34

During the past 13 years, Vitasora Health's highest PS Ratio was 16.00. The lowest was 3.67. And the median was 12.00.

ASX:VHL's PS Ratio is ranked worse than
74.89% of 657 companies
in the Healthcare Providers & Services industry
Industry Median: 1.5 vs ASX:VHL: 4.34

Vitasora Health's Revenue per Sharefor the six months ended in Dec. 2025 was A$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

During the past 13 years, Vitasora Health's highest 3-Year average Revenue per Share Growth Rate was 11.90% per year. The lowest was -23.70% per year. And the median was -15.70% per year.

Back to Basics: PS Ratio


Vitasora Health  (ASX:VHL) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Vitasora Health PS Ratio Related Terms


Vitasora Health PS Ratio Historical Data

* Premium members only.

The historical data trend for Vitasora Health's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitasora Health PS Ratio Chart

Vitasora Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 19.50

Vitasora Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 19.50 0.00

ASX:VHL vs VEEV, BTSG, TEM: PS Ratio Comparison

For the Health Information Services subindustry, Vitasora Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitasora Health PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's PS Ratio distribution charts can be found below:

* The bar in red indicates where Vitasora Health's PS Ratio falls into.



Vitasora Health PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Vitasora Health's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.013/0.003
=4.33

Vitasora Health's Share Price of today is A$0.013.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vitasora Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 4.33 mean?
Vitasora Health (ASX:VHL) has a PS Ratio of 4.33 as of Jul. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vitasora Health and its competitors. This is 64% below median its historical median of 12.00. Over the past decade, Vitasora Health's PS Ratio has ranged from 3.67 to 16.00. According to the industry distribution chart, Vitasora Health ranks #492 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 74.9%.
Is Vitasora Health's PS Ratio too high?
Vitasora Health's current PS Ratio of 4.33 is 64% below median its 10-year median of 12.00. Over the past 10 years, this metric has ranged from a low of 3.67 to a high of 16.00. The Healthcare Providers & Services industry median PS Ratio is 1.50. Vitasora Health's value of 4.33 is 188.7% above this industry median. Based on the distribution chart, Vitasora Health ranks #492 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Vitasora Health's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #492 out of 657 companies for PS Ratio. This places Vitasora Health in the lower half of its industry. The industry median PS Ratio is 1.50. Vitasora Health's value of 4.33 is 188.7% above this benchmark. Historically, Vitasora Health's own PS Ratio has ranged from 3.67 to 16.00 over the past decade. While the company's 10-year median is 12.00 vs. the industry median of 1.50, Vitasora Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitasora Health's current PS Ratio of 4.33 is 188.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vitasora Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current PS Ratio is 4.33, which is 64% below median its own 10-year median of 12.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current PS Ratio of 4.33. The current PS Ratio is 4.33, which is 64% below median its 10-year median of 12.00 and 188.7% above the Healthcare Providers & Services industry median of 1.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current PS Ratio is 4.33 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitasora Health Business Description

Other Exchanges VHLUF:USA
Address 432 Street Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.